CompletedNot Applicable

Anatomical Resection in Colorectal Liver Metastases Patients

729 participantsStarted 2012-06-01

Plain-language summary

The type of liver resection (anatomical resection, AR or nonanatomical resection, NAR) for colorectal liver metastases (CRLM) is subject to debate. The debate may persist because some certain prognostic factors, associated with aggressive biological behavior of tumor, have been overlooked. The aim of our study was to investigate the characteristics of patients who would benefit more from anatomical resection for colorectal liver metastases.

Who can participate

Age range18 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: (1)Age 18-79 years;(2) Histologically proven colorectal adenocarcinoma; Exclusion Criteria: (1) the histologic type of tumor was not called adenocarcinoma; (2) peritoneal metastasis; (3) number of liver metastasis \>3; (4) simultaneous anatomical and nonanatomical resections; (5) R2 resection; (6) history of previous hepatectomy; (7) incomplete data. The rest of patients were divided into 2 groups: patients undergoing an AR, and patients undergoing a NAR.

What they're measuring

RFS

Timeframe: 2012.6.1-2022.6.1

Trial details

NCT IDNCT05673564

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-05-01

View on ClinicalTrials.gov More The Characteristics of CRLM Patients Who Would Benefit More From Anatomical Resection trials